Search

Search Constraints

You searched for: Author/Creator Hunter, Zachary R.

Search Results

1. A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemia. Issue 6 (11th May 2020)

2. Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next‐generation sequencing in Waldenström macroglobulinaemia. (13th March 2021)

3. Cell‐free DNA analysis for detection of MYD88L265P and CXCR4S338X mutations in Waldenström macroglobulinemia. Issue 7 (22nd April 2021)

4. Clonal architecture of CXCR4 WHIM‐like mutations in Waldenström Macroglobulinaemia. (13th December 2015)

6. CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib. (3rd July 2019)

7. CXCR4 mutational status does not impact outcomes in patients with Waldenström macroglobulinemia treated with proteasome inhibitors. Issue 4 (23rd January 2020)

8. CXCR4 WHIM‐like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88L265P‐directed survival signalling in Waldenström macroglobulinaemia cells. (5th November 2014)

9. Deepening of response after completing rituximab‐containing therapy in patients with Waldenstrom macroglobulinemia. Issue 4 (7th January 2020)

10. Diagnostic Next-generation Sequencing Frequently Fails to Detect MYD88L265P in Waldenström Macroglobulinemia. Issue 8 (19th August 2021)